ERBB2 and neoplasm: According to our findings there was no correlation between the promoter methylation status of these genes in the EpCAM-positive CTC-fraction and tumour size, number of lymph nodes, tumour grade, tumour stage, the presence of progesterone (PR) and estrogen receptors (ER), HER2 status, and age (data not shown).